We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+11.96%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$109B
AUM Growth
+$5.89B
(+5.7%)
Cap. Flow
-$3.72B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
32.97%
Holding
343
New
8
Increased
53
Reduced
229
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$164M |
| 2 |
Fidelity National Information Services
FIS
|
+$140M |
| 3 |
Intel
INTC
|
+$124M |
| 4 |
GSK
GSK
|
+$111M |
| 5 |
Mobileye
MBLY
|
+$62.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$753M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
+$370M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$197M |
| 5 |
Morgan Stanley
MS
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.81% |
| 2 | Technology | 27.17% |
| 3 | Industrials | 11.89% |
| 4 | Financials | 8.82% |
| 5 | Consumer Discretionary | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
UnitedHealth
UNH
$373B
| $8.5M | 0.01% |
16,034
| – | – |
|
|
GTM
252
ZoomInfo Technologies
GTM
$1.25B
| $8.3M | 0.01% |
275,569
-2,950
| -1% | -$102K |
|
253
Darden Restaurants
DRI
$24.3B
| $8.26M | 0.01% |
59,700
| – | – |
|
|
CYBR
254
DELISTED
CyberArk
CYBR
| $8.2M | 0.01% |
63,250
-16,100
| -20% | -$2.33M |
|
255
Repligen
RGEN
$9.31B
| $8.02M | 0.01% |
47,379
| – | – |
|
256
New Fortress Energy
NFE
$99.9M
| $7.95M | 0.01% |
187,300
+1,700
| +0.9% | +$82.1K |
|
257
SLB Ltd
SLB
$76.9B
| $7.86M | 0.01% |
147,100
+8,000
| +6% | +$398K |
|
|
PRO
258
DELISTED
PROS Holdings
PRO
| $7.71M | 0.01% |
317,630
-29,660
| -9% | -$727K |
|
259
Enovis
ENOV
$1.5B
| $7.66M | 0.01% |
143,066
| – | – |
|
260
Ambarella
AMBA
$3.71B
| $7.52M | 0.01% |
91,400
-22,300
| -20% | -$1.48M |
|
261
DoorDash
DASH
$92.2B
| $7.13M | 0.01% |
145,990
-300
| -0.2% | -$15.6K |
|
262
Constellation Brands
STZ
$22.8B
| $6.98M | 0.01% |
30,100
| – | – |
|
263
BridgeBio Pharma
BBIO
$16.7B
| $6.96M | 0.01% |
913,292
-124,438
| -12% | -$1.19M |
|
264
ESAB
ESAB
$5.4B
| $6.71M | 0.01% |
143,065
| – | – |
|
265
Omnicell
OMCL
$1.7B
| $6.61M | 0.01% |
131,107
+21,850
| +20% | +$1.31M |
|
266
Rapid7
RPD
$782M
| $6.58M | 0.01% |
193,500
+12,900
| +7% | +$461K |
|
267
Rivian
RIVN
$23.1B
| $6.4M | 0.01% |
347,500
-4,520
| -1% | -$133K |
|
268
GitLab
GTLB
$6.8B
| $5.99M | 0.01% |
131,790
-1,030
| -0.8% | -$46.5K |
|
269
Dollar General
DG
$27B
| $5.81M | 0.01% |
23,600
+6,500
| +38% | +$1.61M |
|
|
AMK
270
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $5.79M | 0.01% |
251,700
| – | – |
|
271
EPR Properties
EPR
$4.69B
| $5.59M | 0.01% |
148,280
-23,720
| -14% | -$923K |
|
272
Guardant Health
GH
$22.9B
| $5.5M | 0.01% |
202,044
-27,000
| -12% | -$1.24M |
|
273
Standard BioTools
LAB
$310M
| $5.4M | ﹤0.01% |
4,616,673
-310,070
| -6% | -$382K |
|
274
Ciena
CIEN
$58.3B
| $5.17M | ﹤0.01% |
101,485
+1,000
| +1% | +$45.2K |
|
275
Health Catalyst
HCAT
$130M
| $5.01M | ﹤0.01% |
471,334
-910
| -0.2% | -$8.79K |
|
Similar funds
VAM
Primecap Management's Q4 2022 Portfolio in Review
As of Q4 2022, Primecap Management held 343 positions worth $109B, up 5.7% from $103B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Primecap Management withdrew a net $3.72B in Q4 2022, closing 9 positions and reducing 229 holdings. Its most notable exit was Abiomed Inc, an estimated $370M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 33% a quarter earlier, followed by Technology and Industrials.
Against the trend, Primecap Management opened a new position in Mobileye worth $72.3M.
- Primecap Management's largest Q4 2022 buy was Mobileye: 2,061,470 shares worth $72.3M.
- Primecap Management added most to Splunk Inc in Q4 2022, an estimated $164M increase.
- Primecap Management's biggest Q4 2022 reduction was Eli Lilly, cutting an estimated $753M.
- Primecap Management fully exited Abiomed Inc in Q4 2022, selling an estimated $370M.
- Primecap Management's ten largest holdings make up 33% of its $109B portfolio in Q4 2022.
- Primecap Management opened 8 new positions and closed 9 in Q4 2022.
- Primecap Management's portfolio value rose 5.7% quarter-over-quarter to $109B.
Based on Primecap Management's 13F filing for Q4 2022, filed 13 Feb 2023.